Clinical Trial

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The objective of this phase III trial to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-07-29.
Trial Details
NCT Number NCT05970783
Lead Sponsor Beijing Konruns Pharmaceutical Co., Ltd.
Conditions Chronic Pelvic Pain
Enrollment 414 participants
Start Date 2022-11-08
Primary Completion 2024-03-11 (estimated)
Study Completion 2025-04 (estimated)
Updated on ClinicalTrials.gov 2024-10-17